1. Home
  2. SER vs PHUN Comparison

SER vs PHUN Comparison

Compare SER & PHUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SER
  • PHUN
  • Stock Information
  • Founded
  • SER 2017
  • PHUN 2009
  • Country
  • SER United States
  • PHUN United States
  • Employees
  • SER N/A
  • PHUN N/A
  • Industry
  • SER Biotechnology: Pharmaceutical Preparations
  • PHUN EDP Services
  • Sector
  • SER Health Care
  • PHUN Technology
  • Exchange
  • SER Nasdaq
  • PHUN Nasdaq
  • Market Cap
  • SER 56.5M
  • PHUN 64.1M
  • IPO Year
  • SER 2018
  • PHUN N/A
  • Fundamental
  • Price
  • SER $5.40
  • PHUN $2.67
  • Analyst Decision
  • SER Strong Buy
  • PHUN Buy
  • Analyst Count
  • SER 2
  • PHUN 2
  • Target Price
  • SER $13.00
  • PHUN $7.75
  • AVG Volume (30 Days)
  • SER 25.7K
  • PHUN 351.1K
  • Earning Date
  • SER 08-11-2025
  • PHUN 08-08-2025
  • Dividend Yield
  • SER N/A
  • PHUN N/A
  • EPS Growth
  • SER N/A
  • PHUN N/A
  • EPS
  • SER N/A
  • PHUN N/A
  • Revenue
  • SER $130,000.00
  • PHUN $2,400,000.00
  • Revenue This Year
  • SER N/A
  • PHUN $3.01
  • Revenue Next Year
  • SER N/A
  • PHUN $50.72
  • P/E Ratio
  • SER N/A
  • PHUN N/A
  • Revenue Growth
  • SER N/A
  • PHUN N/A
  • 52 Week Low
  • SER $3.81
  • PHUN $2.22
  • 52 Week High
  • SER $10.28
  • PHUN $14.60
  • Technical
  • Relative Strength Index (RSI)
  • SER 48.70
  • PHUN 40.59
  • Support Level
  • SER $5.02
  • PHUN $2.50
  • Resistance Level
  • SER $5.63
  • PHUN $2.88
  • Average True Range (ATR)
  • SER 0.40
  • PHUN 0.14
  • MACD
  • SER 0.02
  • PHUN -0.01
  • Stochastic Oscillator
  • SER 29.03
  • PHUN 28.00

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

About PHUN Phunware Inc.

Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States. The company has two reportable segments: Software subscriptions and services; and Advertising. It derives maximum revenue from Software subscriptions and services.

Share on Social Networks: